Myths About Bipolar Affective Disorder: The Role of Structured Group

Status Recruiting

Clinical Trial Summary

This study will examine:

1) The impact of psycho education group therapy sessions relating to beliefs/myths associated with bipolar affective disorder (BAD) on the emotional wellbeing, clinical course and cognition of individuals diagnosed with BAD 2) Will examine the existence of those same beliefs among the various caregivers - psychiatrists, general practitioners, social workers, and psychiatric nurses.

The investigators hypothesize that psychoeducation group therapy will be effective in refuting the myths and will lead to better treatment adherence, longer remissions, fewer hospitalizations, improved self esteem, increased optimism, and better control over the disease process. The investigators also believe that they will identify some beliefs/myths or preconceived notions that are common to both caregivers and individuals with BAD.

Clinical Trial Description

Methods:

Effect psychoeducation:

Study population - 30 patients diagnosed with BAD treated in the outpatient clinic, in a state of remission will be evaluated with the Hamilton Rating Scale for Depression, Young Mania Rating Scale, and will then participate in 7 weekly sessions of brief structured psycho education therapy Control group - 30 patients diagnosed with BAD treated in the outpatient clinic, in a state of remission will be evaluated with the Hamilton Rating Scale for Depression, Young Mania Rating Scale. In addition both groups will complete the Snyder Hope Scale, Accepting the Mental Illness Label Scale and a questionnaire regarding Myths in BAD prior to the study, and when the study group finishes their group therapy sessions. (Controls will not participate in the psychoeducation group therapy).

Caregivers beliefs:

50 caregivers from various professions will complete the questionnaire regarding the myths, once only. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00474357
Study type	Interventional
Source	Lev-Hasharon Mental Healtlh Center
Contact	Deby Peres, MD
Phone	+972-9-8981242
Email	debyp@lev-hasharon.co.il
Status	Recruiting
Phase	N/A
Start date	May 2007
Completion date	October 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03275714` - Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder	N/A
Completed	`NCT03249857` - Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.	N/A
Completed	`NCT01722344` - Improving Work Outcome for People With Severe Mental Illness	N/A
Completed	`NCT01431092` - Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia	Phase 4
Completed	`NCT01315028` - Bipolar Intervention Study: Cognitive Interpersonal Therapy	N/A
Terminated	`NCT00805493` - Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder	Phase 2
Completed	`NCT00436020` - rTMS in the Treatment of Bipolar Depression	N/A
Withdrawn	`NCT00397605` - Cannabinoids in Bipolar Affective Disorder	N/A
Recruiting	`NCT05860101` - Compassion-Focused Therapy for Distressing Mood Swings: A Case Series	N/A
Recruiting	`NCT06176456` - Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia	N/A
Terminated	`NCT03310593` - Cannabidiol as an Adjunctive Treatment for Bipolar Depression	Phase 2/Phase 3
Recruiting	`NCT05406414` - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems	N/A
Completed	`NCT02773108` - Somatic Comorbidities in Psychiatric Patients
Withdrawn	`NCT00327756` - Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	Phase 2
Completed	`NCT02453217` - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial	N/A
Completed	`NCT05683431` - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)	N/A
Not yet recruiting	`NCT05915312` - Exosome for Early Diagnosis of Bipolar Affective Disorder
Completed	`NCT00186758` - Transcranial Magnetic Stimulation in Bipolar Depression	Phase 4
Completed	`NCT02083978` - Bipolar Research Study Using MR Imaging	N/A
Completed	`NCT00683709` - Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy — BAD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms